YEATS2 regulates the activation of TAK1/NF-κB pathway and is critical for pancreatic ductal adenocarcinoma cell survival

被引:7
|
作者
Sheng, Hao [1 ,2 ,3 ]
Zheng, Fang [1 ]
Lan, Tian [1 ]
Chen, Hang-fei [4 ]
Xu, Chun-yi [4 ]
Wang, Si-wei [1 ]
Weng, Yuan-yuan [1 ,5 ]
Xu, Li-feng [1 ]
Zhang, Feng [1 ,3 ,4 ]
机构
[1] Wenzhou Med Univ, Quzhou Peoples Hosp, Quzhou Affiliated Hosp, Core Facil, Quzhou 324000, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Jiande Branch, Sch Med, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sch Med, Hangzhou, Peoples R China
[4] Zhejiang Chinese Med Univ, Hangzhou, Peoples R China
[5] Wenzhou Med Univ, Quzhou Peoples Hosp, Dept Clin Lab, Quzhou Affiliated Hosp, Quzhou, Peoples R China
关键词
YEATS2; NF-kappa B; TAK1; Pancreatic ductal adenocarcinoma; Histone acetylation; NF-KAPPA-B; KINASE KINASE KINASE; TAK1; GROWTH; PHOSPHORYLATION; COMPLEX; CANCER; INFLAMMATION; EXPRESSION; BINDING;
D O I
10.1007/s10565-021-09671-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The prognosis of pancreatic ductal adenocarcinoma (PDAC) is poor despite diagnostic progress and new chemotherapeutic regimens. Constitutive activation of NF-kappa B is frequently observed in PDAC. In this study, we found that YEATS2, a scaffolding protein of ATAC complex, was highly expressed in human PDAC. Depletion of YEATS2 reduced the growth, survival, and tumorigenesis of PDAC cells. The binding of YEATS2 is crucial for maintaining TAK1 activation and NF-kappa B transcriptional activity. Of importance, our results reveal that YEATS2 promotes NF-kappa B transcriptional activity through modulating TAK1 abundance and directly interacting with NF-kappa B as a co-transcriptional factor.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [41] The Expressions of NF-κB, COX-2, Sp1, and c-Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival
    Renaldi, Kaka
    Simadibrata, Marcellus
    Rahadiani, Nur
    Handjari, Diah Rini
    Harahap, Alida Roswita
    Harimurti, Kuntjoro
    Zubir, Nasrul
    Siregar, Lianda
    Loho, Imelda Maria
    Suzanna, Evlina
    Prawirodihardjo, Bonita
    Hidajat, Heriawaty
    Widodo, Budi
    Rahniayu, Alphania
    Tambun, Renaningtyas
    William, Andy
    Makmun, Dadang
    PATHOPHYSIOLOGY, 2023, 30 (02) : 92 - 109
  • [42] PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1
    Ye, Zhihua
    Yang, Yingyu
    Wei, Ying
    Li, Lamei
    Wang, Xinyi
    Zhang, Junkai
    CELL DEATH & DISEASE, 2022, 13 (07)
  • [43] PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1
    Zhihua Ye
    Yingyu Yang
    Ying Wei
    Lamei Li
    Xinyi Wang
    Junkai Zhang
    Cell Death & Disease, 13
  • [44] The NF-κB activation pathway, its regulation and role in inflammation and cell survival
    Karin, M
    SIGNALLING IN THE LIVER, 1998, 103B : 13 - 25
  • [45] The NF-κB activation pathway:: Its regulation and role in inflammation and cell survival
    Karin, M
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1998, 4 : S92 - S99
  • [46] Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway
    Ye, Bozhi
    Chen, Xudong
    Chen, Yanghao
    Lin, Wante
    Xu, Diyun
    Fang, Zimin
    Chattipakorn, Nipon
    Huang, Weijian
    Wang, Xu
    Wu, Gaojun
    Liang, Guang
    PHYTOMEDICINE, 2023, 108
  • [47] A critical role of TAK1 in B-cell receptor-mediated nuclear factor κB activation
    Schuman, James
    Chen, Yuhong
    Podd, Andrew
    Yu, Mei
    Liu, Hong-Hsing
    Wen, Renren
    Chen, Zhijian J.
    Wang, Demin
    BLOOD, 2009, 113 (19) : 4566 - 4574
  • [48] TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-κB
    Uemura, N
    Kajino, T
    Sanjo, H
    Sato, S
    Akira, S
    Matsumoto, K
    Ninomiya-Tsuji, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (12) : 7863 - 7872
  • [49] TAK1 prevents TRAIL-induced cell death through an NF-κB-independent mechanism
    Morioka, Sho
    Omori, Emily
    Kajino, Taisuke
    Kajino-Sakamoto, Pie
    Matsumoto, Kunihiro
    Ninomiya-Tsuji, Jun
    FASEB JOURNAL, 2008, 22
  • [50] TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-κB Dependent Induction of cFLIPL
    Lluis, Josep Maria
    Nachbur, Ulrich
    Cook, Wendy Diane
    Gentle, Ian Edward
    Moujalled, Donia
    Moulin, Maryline
    Wong, Wendy Wei-Lynn
    Khan, Nufail
    Chau, Diep
    Callus, Bernard Andrew
    Vince, James Edward
    Silke, John
    Vaux, David Lawrence
    PLOS ONE, 2010, 5 (01):